Cibc World Market Inc. Crispr Therapeutics Ag Transaction History

Cibc World Market Inc.

$47.5 Billion
Q2 2025

A detailed history of Cibc World Market Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Cibc World Market Inc. holds 14,109 shares of CRSP stock, worth $874,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,109

Previous 11,324 24.59%

Holding current value

$874,334

Previous $385,000 78.18%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$31.27 - $48.64 $87,086 - $135,462	2,785 Added 24.59%	14,109 $686,000
Q1 2025 May 14, 2025	BUY	$34.03 - $53.02 $88,409 - $137,745	2,598 Added 29.77%	11,324 $385,000
Q4 2024 Jan 23, 2025	SELL	$38.65 - $55.15 $101,958 - $145,485	-2,638 Reduced 23.21%	8,726 $343,000
Q3 2024 Nov 12, 2024	SELL	$44.62 - $62.75 $50,643 - $71,221	-1,135 Reduced 9.08%	11,364 $534,000
Q2 2024 Aug 07, 2024	SELL	$51.17 - $68.18 $39,759 - $52,975	-777 Reduced 5.85%	12,499 $675,000
Q1 2024 May 13, 2024	SELL	$60.67 - $89.12 $25,117 - $36,895	-414 Reduced 3.02%	13,276 $905,000
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $132,814 - $248,227	3,439 Added 33.55%	13,690 $857,000
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $49,702 - $64,605	1,095 Added 11.96%	10,251 $465,000
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $8,607 - $13,418	-198 Reduced 2.12%	9,156 $514,000
Q1 2023 May 12, 2023	BUY	$41.0 - $56.12 $16,810 - $23,009	410 Added 4.58%	9,354 $423,000
Q4 2022 Feb 13, 2023	SELL	$39.19 - $65.67 $666 - $1,116	-17 Reduced 0.19%	8,944 $364,000
Q3 2022 Nov 10, 2022	SELL	$61.1 - $83.78 $25,478 - $34,936	-417 Reduced 4.45%	8,961 $586,000
Q2 2022 Aug 10, 2022	BUY	$43.23 - $73.83 $44,267 - $75,601	1,024 Added 12.26%	9,378 $570,000
Q1 2022 May 12, 2022	BUY	$53.19 - $79.24 $146,804 - $218,702	2,760 Added 49.34%	8,354 $524,000
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $58,875 - $93,483	-840 Reduced 13.06%	5,594 $424,000
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $577,888 - $821,420	-5,244 Reduced 44.9%	6,434 $720,000
Q2 2021 Aug 12, 2021	BUY	$100.84 - $161.89 $753,476 - $1.21 Million	7,472 Added 177.65%	11,678 $1.89 Million
Q1 2021 May 11, 2021	BUY	$110.72 - $210.04 $216,346 - $410,418	1,954 Added 86.77%	4,206 $513,000
Q4 2020 Feb 08, 2021	BUY	$79.67 - $173.23 $179,416 - $390,113	2,252 New	2,252 $345,000
Q3 2018 Nov 09, 2018	SELL	$44.35 - $65.71 $622,141 - $921,779	-14,028 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$42.62 - $73.59 $480,327 - $829,359	-11,270 Reduced 44.55%	14,028 $824,000
Q1 2018 May 18, 2018	BUY	$23.52 - $58.17 $595,008 - $1.47 Million	25,298 New	25,298 $1.16 Million

Others Institutions Holding CRSP

# of Institutions

541

Shares Held

68.5M

Call Options Held

3.67M

Put Options Held

2.25M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.83B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Crispr Therapeutics Ag Transaction History